Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05956782 · ClinicalTrials.gov registry record · NA
Breathe Easier II: A Dyad-based Multiple Behavior Intervention
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05956782 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 40 participants.
The verdict
NCT05956782, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This pilot randomized control trial (RCT) will test a 12-week, multiple behavior intervention physical activity and stress management for survivors with early stage lung cancer (stages I-III) and their family members (1 survivor + 1 family member or friend = 1 dyad). The long-term goal of this research is to improve health outcomes for survivors of lung cancer and their family members. The goals of the intervention, Breathe Easier, are symptom reduction (less breathlessness, less fatigue, less stress) and change in multiple behaviors (increase in stress management and increase in physical activity, and decrease tobacco use - if appropriate). Our aim is: To conduct a 6-month, two-group, pilot randomized control trial intervention study with a pre- and post-test study design to estimate preliminary intervention effects on (a) reduction of symptoms (breathlessness, fatigue, and stress) in survivors of non small cell lung cancer (stages I-III) and family members or friends; (b) increase in physical activity behaviors immediately following the intervention and at 3-months; (c) increase in stress management strategies immediately following the intervention and at 3-months; (d) reduction in smoking behavior among participants who smoke tobacco products at study entry immediately following the intervention at 3-months.
Interventions
- BEHAVIORAL Breathe Easier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05956782
The ClinicalTrials.gov registry entry for NCT05956782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breathe Easier is the first listed.
NCT05956782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05956782 about?
NCT05956782 is a clinical study titled "Breathe Easier II: A Dyad-based Multiple Behavior Intervention". This pilot randomized control trial (RCT) will test a 12-week, multiple behavior intervention physical activity and stress management for survivors with early stage lung cancer (stages I-III) and their family members (1 survivor + 1 family member or friend = 1 dyad). The long-term goal of this resea...
What is the current status of trial NCT05956782?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-06-15. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT05956782?
The interventions under investigation include: Breathe Easier (BEHAVIORAL).
Who is sponsoring clinical trial NCT05956782?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.